Liver RFA is the most well-established indication, as reflected by the number of peer-reviewed reports on this topic: more than 50 between 2003 and 2005. One of the studies included 1000 patients. Reports include general reviews but also address survival rates, comparative studies, evaluation of tumor response, complications, combination therapies, imaging strategies, cost evaluations, and variations in technique. More »

Painful metastatic bone cancer is often found in connection with soft-tissue organ tumors. Thirteen peer-reviewed reports published in the 2003-2004 time period address the use of RFA to treat bone tumors. More »

Lung cancer is one of the newer applications for RFA. Research papers from the peer-reviewed literature listed here often represent initial series or experiences observed by the authors. Included is one paper on patient selection and a report on a survey of international studies of the topic. Thirteen papers span the period from 2003 to 2005. More »